EP0957908A4 - FIBRINOGENIC RECEPTOR ANTAGONISTS - Google Patents

FIBRINOGENIC RECEPTOR ANTAGONISTS

Info

Publication number
EP0957908A4
EP0957908A4 EP97952350A EP97952350A EP0957908A4 EP 0957908 A4 EP0957908 A4 EP 0957908A4 EP 97952350 A EP97952350 A EP 97952350A EP 97952350 A EP97952350 A EP 97952350A EP 0957908 A4 EP0957908 A4 EP 0957908A4
Authority
EP
European Patent Office
Prior art keywords
fibrinogenic
receptor antagonists
antagonists
receptor
fibrinogenic receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97952350A
Other languages
German (de)
French (fr)
Other versions
EP0957908A1 (en
Inventor
Melissa S Egbertson
Laura M Vassallo
George D Hartman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9702834.4A external-priority patent/GB9702834D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP0957908A1 publication Critical patent/EP0957908A1/en
Publication of EP0957908A4 publication Critical patent/EP0957908A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/14Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/23Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/27Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/36Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EP97952350A 1996-12-13 1997-12-09 FIBRINOGENIC RECEPTOR ANTAGONISTS Withdrawn EP0957908A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3288896P 1996-12-13 1996-12-13
US32888P 1996-12-13
GB9702834 1997-02-12
GBGB9702834.4A GB9702834D0 (en) 1997-02-12 1997-02-12 Fibrinogen receptor antagonists
PCT/US1997/022622 WO1998025601A1 (en) 1996-12-13 1997-12-09 Fibrinogen receptor antagonists

Publications (2)

Publication Number Publication Date
EP0957908A1 EP0957908A1 (en) 1999-11-24
EP0957908A4 true EP0957908A4 (en) 2003-03-12

Family

ID=26310974

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97952350A Withdrawn EP0957908A4 (en) 1996-12-13 1997-12-09 FIBRINOGENIC RECEPTOR ANTAGONISTS

Country Status (5)

Country Link
EP (1) EP0957908A4 (en)
JP (1) JP2001506633A (en)
AU (1) AU719495B2 (en)
CA (1) CA2274029A1 (en)
WO (1) WO1998025601A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030181488A1 (en) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039805A (en) * 1988-12-08 1991-08-13 Hoffmann-La Roche Inc. Novel benzoic and phenylacetic acid derivatives
JPH08504194A (en) * 1992-12-01 1996-05-07 メルク エンド カンパニー インコーポレーテッド Fibrinogen receptor antagonist
US5563158A (en) * 1993-12-28 1996-10-08 The Dupont Merck Pharmaceutical Company Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO9825601A1 *

Also Published As

Publication number Publication date
JP2001506633A (en) 2001-05-22
WO1998025601A1 (en) 1998-06-18
AU719495B2 (en) 2000-05-11
CA2274029A1 (en) 1998-06-18
AU5598198A (en) 1998-07-03
EP0957908A1 (en) 1999-11-24

Similar Documents

Publication Publication Date Title
DE69734833D1 (en) VITRONEKTIN RECEPTOR ANTAGONISTS
NO972016D0 (en) Indolyl-Y receptor antagonists
BR9709952A (en) Il-8 receptor antagonists
NO986109D0 (en) IL-8 receptor antagonists
DE69812096D1 (en) NEUROPEPTID Y RECEPTOR ANTAGONISTS
NO951613D0 (en) Non-peptidyl tachykinin receptor antagonists
EP0885205A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
EP0986385A4 (en) GONADOLIBERINE ANTAGONISTS
BR9508178A (en) Vitronectin receptor antagonists
EP0810994A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
FI955223A7 (en) Adhesion receptor antagonists
NO20012411D0 (en) Pyrrolidine derivatives-CCR-3 receptor antagonists
NO983737D0 (en) IL-8 receptor antagonists
ATE280157T1 (en) 4-AROYL-PIPERIDINE-CCR-3 RECEPTOR ANTAGONISTS III
BR9711140A (en) Il-8 receptor antagonists
EP0866705A4 (en) FIBRINOGEN RECEPTOR ANTAGONISTS
ID24726A (en) TROMBIN RECEPTOR ANTAGONISTS
FI960516A7 (en) Substituted biphenylsulfonamide dientothelin antagonists
DK0906294T3 (en) Benzoxazinone-dopamine D4 receptor antagonists
NO950606D0 (en) Adhesion receptor antagonists
BR9707733A (en) Oxa-e-thia-diazole muscarinic receptor antagonists
ID24162A (en) VITRONECTTIN RECEPTOR ANTAGONISTS
EP0929218A4 (en) R2Y RECEPTOR ANTAGONISTS
FI955351A7 (en) Adhesion receptor antagonists
BR9507220A (en) Endothelin receptor antagonists

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990713

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20030127

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 45/06 B

Ipc: 7C 07D 333/34 B

Ipc: 7C 07C 311/19 B

Ipc: 7C 07C 311/14 B

Ipc: 7C 07C 311/27 A

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030415